abstract |
The present invention provides an ACVR1-Fc fusion protein, a nucleic acid for encoding the fusion protein, a carrier and host cell containing the nucleic acid, a method for preparing the fusion protein, and applications of the foregoing substances in prevention and/or treatment of diseases or symptoms relevant to ACVR1 abnormality (e.g., ACVR1 mutation and/or excessive activation). |